Last update 07 Jul 2025

HZBio-2

Overview

Basic Info

Drug Type
Probiotics
Synonyms
HZBIO 2, HZBIO-2, HZBIO2
Target-
Action
modulators
Mechanism
Bacteria replacements, Microbiome modulators
Therapeutic Areas
Immune System DiseasesDigestive System Disorders
Active Indication
Colitis, UlcerativeCrohn Disease
Inactive Indication-
Originator Organization
Hangzhou Grand Biologic Pharmaceutical Inc.Hangzhou Grand Biologic Pharmaceutical Inc.
Active Organization
Hangzhou Grand Biologic Pharmaceutical Inc.Hangzhou Grand Biologic Pharmaceutical Inc.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 3
First Approval Date-
Regulation-
Login to view timeline

Related

2
Clinical Trials associated with HZBio-2
CTR20221111
/ CompletedPhase 1
一项随机、双盲、平行对照，比较注射用HZBio2与安吉优®在健康成年男性受试者中的药代动力学特征的I期临床研究
[Translation] A randomized, double-blind, parallel-controlled Phase I clinical study comparing the pharmacokinetic characteristics of HZBio2 for injection and Anjiyou® in healthy adult male subjects
CTR20252645
/ Not yet recruitingPhase 3
评价HZBio2治疗中国成人中重度活动性溃疡性结肠炎患者的有效性和安全性的多中心、随机、双盲、阳性对照、平行设计的Ⅲ期研究
[Translation] A multicenter, randomized, double-blind, positive-controlled, parallel-design phase III study to evaluate the efficacy and safety of HZBio2 in the treatment of Chinese adult patients with moderately to severely active ulcerative colitis
100 Clinical Results associated with HZBio-2
Login to view more data
100 Translational Medicine associated with HZBio-2
Login to view more data
100 Patents (Medical) associated with HZBio-2
Login to view more data
100 Deals associated with HZBio-2
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Colitis, UlcerativePhase 3
China
Hangzhou Grand Biologic Pharmaceutical Inc.Hangzhou Grand Biologic Pharmaceutical Inc.
04 Jul 2025
Crohn DiseasePhase 3
China
Hangzhou Grand Biologic Pharmaceutical Inc.Hangzhou Grand Biologic Pharmaceutical Inc.
04 Jul 2025
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free